LEADER 00823nam a22002531i 4500
001 991001717829707536
008 062006|2006    it       |    0|0|0|ita d
020   $a8804550341
035   $ab13416571-39ule_inst
040   $aDip.to Filologia Ling. e Lett.$bita
041 0 $aita
044   $ait
082 0 $a853.914
100   $aCotroneo, Roberto$0164118
245 10$aQuesto amore /$cRoberto Cotroneo
260   $aMilano :$bMondadori,$c2006
300   $a137 p.$c22 cm.
440 0 $aScrittori italiani e stranieri
907   $a.b13416571$b21-09-06$c23-06-06
912   $a991001717829707536
945   $aLE008 TS M I 490$g1$i2008000095529$lle008$o-$pE0.00$q-$rl$s-  $t0$u0$v0$w0$x0$y.i14257427$z23-06-06
996   $aQuesto amore$91091808
997   $aUNISALENTO
998   $ale008$b23-06-06$cm$da  $e-$fita$git $h0$i0

LEADER 01443nam  2200445   450 
001 9910136575003321
005 20180410223400.0
010   $a1-5361-0228-8
035   $a(CKB)3710000000908027
035   $a(MiAaPQ)EBC4730539
035   $a(EXLCZ)993710000000908027
100   $a20161110h20162016  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aDrug development and rare pediatric diseases $eissues, strategic plan, and voucher program assessment /$fFrederick Johnston, editor
210  1$aNew York, [New York] :$cNova Biomedical,$d2016.
210  4$dİ2016
215   $a1 online resource (140 pages) $cillustrations, tables
225 1 $aPharmacology - Research, Safety Testing and Regulation
300   $aIncludes index.
311   $a1-5361-0227-X 
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aPediatric pharmacology
606   $aDrug development
606   $aChildren$xDiseases$xTreatment
615  0$aPediatric pharmacology.
615  0$aDrug development.
615  0$aChildren$xDiseases$xTreatment.
676   $a615.1083
702   $aJohnston$b Frederick
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910136575003321
996   $aDrug development and rare pediatric diseases$92890079
997   $aUNINA